BHK-21 cells readily produce tumours in athymic nude mice, but BHK-21 cells persistently infected with wild-type vesicular stomatitis virus (VSV) do not. However, rare persistently infected virus-shedding tumours (VSV-P tumour cells) were independently derived by in vivo selection on three different occasions. Cloned viruses isolated from each of these (VSV-P virus mutants) carried mutations determining the VSV-P phenotype because they all allowed growth of virus-shedding tumours in nude mice when they were used to persistently infect normal (unselected) BHK-21 cells. Treatment of nude mice with anti-asialo-GM1 allowed BHK cells persistently infected with wild-type VSV to form tumours, and BHK cells persistently infected with VSV-P were resistant to natural killer (NK) cells #z vitro; this implicates NK cells in the in vivo rejection of persistently infected tumours and in the selection of the VSV-P variant. In this paper, we have sequenced the glycoprotein (G protein), matrix (M) and nonstructural (NS) proteins of three independently derived VSV-P type mutants to find mutations associated with in vivo passage of persistently infected nude mouse tumours and with resistance to NK cells. We found extensive mutation in the G protein of VSV-P but relatively few mutations in the M and NS proteins. This suggests but does not prove a role for the G protein in NK cell killing of infected cells. t Present address:
INTRODUCTION
RNA viruses are known to exhibit high mutation frequencies (for review, see Holland et al., 1982) . While RNA viruses such as vesicular stomatitis virus (VSV) can show genetic stability during low multiplicity lytic passage in vitro, passages at high multiplicity of infection or persistent infections induce rapid evolution of the virus population Spindler et al., 1982; Youngner et al., 1978) . This rapid evolution of RNA viruses makes possible the selection of useful virus mutants requiring multiple genomic sequence changes. Previous work in this and other laboratories has shown that interaction of virus and defective interfering (DI) particle populations during high multiplicity virus passaging and during persistent viral infections in BHK-21 cells selects for virus and DI virus variants with altered interference properties, many mutations at the ends of both virus and DI genomes (Rowlands et al., 1980; Horodyski et al., 1983; O'Hara et al., 1984a, b) and temperature-sensitive mutations (Youngner et al., 1981) . Rapid evolution occurs throughout the viral genome during serial high multiplicity in vitro passages and during persistent infection in vitro or in vivo, with amino acid substitutions occurring in all viral gene products (Rowlands et al., 1980) . We have previously utilized the rapid evolution of VSV during persistent infection of tumour cells in nude mice to isolate a mutant of VSV called VSV-P . BHK-21 cells persistently infected with VSV-P are resistant to natural killer (NK) cells in vitro and form tumours in nude mice, while BHK-21 cells persistently infected with wild-type VSV are sensitive to NK cells in vitro and do not form tumours in nude mice (Minato et al., 1979) . T~ oligonucleotide maps showed that VSV-P s.B. VANDEPOL AND J. J. HOLLAND underwent extensive mutation during its selection in vivo in persistently infected BHK-21 cells, and subsequent nude mouse passaging of BHK-21 cells persistently infected with VSV-P revealed continuing rapid evolution of VSV-P in vivo Spindler et al., 1982) . In this study, we have sequenced the RNA of VSV-P mutants to determine sites of mutation.
Nucleic acid sequencing of antibody-selected variants of a variety of RNA viruses has shown mutations associated with antibody-binding epitopes in viral glycoproteins (Wiley et al., 1981 ; Seif et al., 1985; Skehel et al., 1984; Dietzschold et al., 1983; Hovanec & Air, 1985) . In this paper, we have sequenced the VSV-P glycoprotein (G protein), matrix (M) protein and nonstructural (NS) proteins of three independently derived VSV-P mutants of VSV. The results show that these NK cell-resistant mutants selected in vivo all accumulated extensive mutations in the surface G protein but only relatively few changes in the membrane M protein or the transcriptase-associated NS protein.
METHODS
Ceils and virus strains. BHK-21 cells were originally obtained from the American Type Culture Collection and were maintained in Eagle's MEM with 5 % heat-inactivated calf serum, glutamine and antibiotics. Mutant tsG31 (a temperature-sensitive mutant of VSV-Indiana) and its homologous DI particle were used to establish a persistent infection (called CA R-4) in BHK-21 cells as previously described (Pringle, 1970; Holland & Villarreal, 1974) . CAR-4 cells were passaged in vitro for 4 years prior to inoculation into nude mice. VSV-P was isolated from a rare nude mouse tumour arising 7 months after inoculation with CAR-4 carrier cells . In this study, we shall refer to the original VSV-P isolate as VSV-PA and later isolates as VSV-PB and VSV-PC. All virus isolates were propagated on BHK-21 cell monolayers at 32 °C and purified as previously described (Holland & Villarreal, 1974) .
Recovery of virus fi'om persistently infected tumours. Minced fragments from persistently infected tumours were co-cultivated with uninfected BHK-21 cell monolayers at 32 °C. Viral cytopathology was usually observed by 48 to 72 h if virus was present, but all cultures were monitored for 10 days. VSV-P mutant viruses recovered following the third passages of VSV-PB and VSV-PC were cloned from a plaque then used to establish new persistent infections in normal unselected BHK-21 cells.
Mice. Six-to 10-week-old BALB/c nude mice were provided by the Athymic Nude Mouse Center (University of California, San Diego) and were maintained in an isolated colony with autoclaved food, water and bedding.
Detection o.1 viral antigens. Persistently infected cells were grown overnight on coverslips, fixed, treated with 0.1 ~o Triton X-100 in saline, washed, incubated with a 1:80 dilution of rabbit anti-VSV-Indiana serum, washed and re-incubated with fluorescein-labeUed goat anti-rabbit IgG (Cappel Laboratories). The cells were observed for immune fluorescence with a Zeiss epifluorescence microscope. VSV antigens were similarly detected in acetonefixed frozen turnout sections. Surface indirect immune fluorescence was performed on live unfixed cells at 0 °C in the presence of 0.05~ sodium azide to prevent capping of surface G protein by antibody.
Purification of viral RNA. RNA was extracted from purified VSV virions by proteinase K digestion and phenolchloroform extraction, followed by an ether extraction and repeated alcohol precipitation.
Chemical synthesis of DNA primers. Complementary DNA primers employed for sequencing were synthesized on a solid support, using the phosphotriester approach essentially as described by Miyoshi et al. (1980) and Ito et al. (1982) .
Primer extension using reverse transcriptase. Gel-purified DNA primer (1 to 10 ng) end-labelled with 3.,p in the 5' position was annealed to between 2 and 4 ~tg of viral RNA and then extended by using 3 units of avian myeloblastosis virus reverse transcriptase (obtained from Life Sciences, St. Petersburg, Fla., U.S.A.) in 20 ~tl reactions containing 50 mM-Tris-HC1 pH 8.3, 70 mM-KC1.8 mu-MgClz, 0.5 mM-dithiothreitol and 0.5 mM each of the four deoxynucleoside triphosphates at 37 °C for 1 h. Product DNA was separated from excess unextended primer on Sephadex G-75 and sequenced (Maxam & Gilbert, 1977) . Six primers (G1 to G6) were used for sequencing the G gene. Their locations and sequences are: G 1,5' CCCGGTTTACTCAGTC-3' located in the M gene 74 bases 3' to the origin of the viral G gene; G2, 5'-TGGTACGGACCGAAG-3 ' 291 bases from the origin of the G gene; G3, 5"-GGGTTGATTCAC-3' 505 bases from G origin; G4, 5'-CAAGGCCTGCAAAATG 3' 725 bases from G origin; G5, 5'-AAAACCCAGGAACCGG-3' 1000 bases from G origin; G6, 5'-AGCTCAAAGGCTCAG-3' 1272 bases from G origin. Three primers (M 1 to M3) were used to sequence the M gene: MI, 5'-ATCCCAATCCA-3' 35 bases from the origin of the M gene; M2, 5' CGGAATGGCA-3' 329 bases from origin of M gene; M3, 5'-GGGAACGATTGAGC-3' 545 bases from M gene origin. Three primers (NS1 to NS3) were used to sequence the NS gene: NS1, 5'-ATTTGACAAATGACCC 3' located towards the 5' end of the viral N gene and 43 bases from the beginning of the NS gene; NS2, 5'-GGCAGCAGATGATGATTCTG-3' 174 bases from NS origin; NS3, 5'-ATCTGGCAGAGTGCAC-3' 468 bases from NS origin. 
Derivation of additional VSV-P type mutants
In an earlier study of VSV-P mutants, we showed that the VSV-P phenotype (of persistently infected cells forming tumours) was due to genetic changes(s) in the virus rather than BHK-21 cells. Because only one VSV-P virus mutant was selected previously (called VSV-PA), we have selected two additional VSV-P mutants to allow sequence comparison. We isolated additional VSV-P type virus mutants by creating a new BHK-21 cell line persistently infected with tsG31 and then inoculating it into nude mice to select for persistently infected tumours. Table 1 shows that this new infected cell line (called BHK/CAR-135) had the same phenotype in nude mice as the original BHK/CAR-4 persistent infection (the original BHK-tsG31 infection from which VSV-PA was selected); none of the nude mice inoculated with BHK/CAR-135 developed tumours, while nude mice pretreated with gamma irradiation or anti-asialo-GM1 did develop tumours. This is consistent with NK cells mediating the rejection (Habu et al., 1981 ; Schattner et al., 1985) . Table 1 also shows that mice inoculated with a new BHK/VSV-P carrier cell line (made from a clonal pool of VSV-P by serial high multiplicity infections of BHK-21 cells) did develop tumours. The original BHK/VSV-P tumour arose from a persistently infected subcutaneous nodule as a rare tumour 7 months after injection of 106 CAR-4 cells. This tumour was then passaged in nude mice seven times prior to the isolation of the virus called VSV-PA used in this study. To speed the selection of new VSV-P type mutants we injected two nude mice with 10 v BHK/CAR-135 cells subcutaneously every 2 to 3 days until over 108 cells had been injected at various locations. The animals developed multiple subcutaneous nodules, and about 10 to 12 weeks after the last injection one of these nodules on each animal began to grow slowly. When each of the tumours reached about 1 cm in size they were excised and minced; the minced tumours were re-inoculated into new nude mice in two parallel passage series. After the third tumour passage a virus-containing cell-free supernatant was obtained by co-cultivation of the infected turnout cells with normal BHK-21 cells. The infectious virus obtained from these cocultivations was cloned, then used to establish a new persistent infection in uninfected BHK-21 cells. This was done to ensure that the tumour-forming phenotype was due to virus mutation and not to selection of a variant BHK cell. The two new persistently infected cell lines both gave rise to tumours. VSV-PB virus characterized below was isolated from a co-cultivation of the fourth nude mouse tumour passage (i.e. three additional passages beyond the first arising tumour), and VSV-PC virus was derived from a co-cultivation of the seventh nude mouse tumour passage. BHK/VSV-PB and BHK/VSV-PC cells produce nude mouse tumours that are slow growing, locally invasive and non-metastatic. This is in contrast to our previously published results with uninfected BHK-21 cells which produce rapidly growing well-encapsulated tumours that are non-invasive and non-metastatic, and BHK/VSV-PA cells which produce rapidly growing, locally invasive metastatic tumours (Minato et al., 1979) . The properties of VSV-PA, VSV-PB and VSV-PC cells are summarized in Table 2 .
Single well-separated plaques of VSV-PB and VSV-PC viruses were used to make working pools of virus which were used to prepare virion RNA for sequencing, as detailed in Methods.
VSV-P mutants exhibit extensive G protein mutations
The locations of G protein mutations in the mutants VSV-PA, VSV-PB and VSV-PC are shown in Fig. 1 with corresponding nucleotide substitutions shown in Table 3 . VSV-PA showed 18 mutations in the G gene with ten amino acid substitutions. Three of these mutations (amino acid positions 38,259,260) corresponded to our previously determined sites of antibody-selected mutations, with positions 259 and 260 corresponding to the major neutralization epitope of the VSV-Indiana serotype (S. VandePol, L. Lefrancois & J. Holland, unpublished) . Table 4 shows the sequential selection of changes at ami.qo acids 259 and 260. During the seven tumour passages that selected VSV-PA, there were four sequential mutations selected at amino acids 259 and 260. Of particular interest are the continuing third position mutations in the codon specifying amino acid 259 (GGT~GGG~GGC in the third, sixth and seventh tumour passage cell all code for glycine). Of 18 antibody-resistant variants which have been sequenced in this Anti-asialo-GM 1 § 3/3 3/3 BHK/VSV-PA None 3/3 3/3 * Nude mice were inoculated subcutaneously on the right flank with 10 b turnout celIs and tumour development was monitored for 12 weeks.
]" NA, Not applicable. :~ Nude mice were given 500 rads t37Cs irradiation 10 days prior to injection. § Mice were given 0.2 ml of 1:10 dilution of rabbit anti-asialo-GM1 (purchased from Wako Chemical, Dallas, Tx., U.S.A.) 2 days before inoculation and every 3 or 4 days thereafter.
BHK-21
CAR-135 Table 3 ). Two of these changes, at positions 266 and 267 were near the highly selected positions 259 and 260 in VSV-PA within the major neutralization epitope (amino acids 257 to 271) (S. VandePol, L. Lefrancois & J. Holland, unpublished) . Three additional changes, at amino acids 277, 279 and 281, did not correspond to changes in VSV-PA. VSV-PC had eight base changes and five amino acid substitutions ( Fig. 1 and Table 3) The nucleotide sequence of the tsG31 G gene cDNA was determined as detailed in Methods and is shown with the deduced amino acid sequence. The signal sequence cleavage site is after amino acid 16 (Cys). There are two N-linked glycosylation sites, at nucleotide 564 (Asn-Ser-Thr) and 1035 (Asn Gly Thr). The putative transmembrane hydrophobic domain extends from nucleotides 1415 to 1485. There are 36 nucleotide changes resulting in 11 amino acid substitutions between the tsG31 sequence (Glasgow strain of VSV-Indiana) and the previously published sequence for the VSV-San Juan strain . Sites of amino acid substitutions listed in Table 3 are for VSV-PA (•), VSV-PB (•) and VSV-PC (A).
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Gly population heterogeneity in the nucleotide sequence with G and C both represented (Table 3) . This was seen in RNA preparations made from high multiplicity (m.o.i. of 1) infections but not seen in sequences from RNA prepared after low multiplicities of infection (m.o.i. < 10 -3, which gave much higher yields of virus). Heterogeneity at these sites (bases 827, 828,829, 830, 859, 861, 865, 866 and 871) was never seen in tsG31 nor in 13 independently selected and sequenced VSV mutants selected for antibody resistance (data not shown). It appears that mutations selected in vivo at these positions were unstable in vitro in the absence of selective pressure, favouring revertants, especially after low m.o.i, infections. Amino acid 267 (bases 828 to 830) was a site of considerable variation in VSV-PA, VSV-PB and VSV-PC. While VSV-PA showed CCT~CCG (no amino acid change) two different VSV-PB plaques showed CCT-,CCC (no amino acid change) and a third VSV-PB plaque showed no mutation in this codon. Three independent plaques of VSV-PC showed either CCT, CTC or CCC at amino acid 267. Neither tsG31 nor 13 independent antibody-resistant isolates have shown any mutations at this amino acid, which are similar to silent mutations at amino acid 259 in VSV-PA. 
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M protein mutations in VSV-P mutants
M gene mutations in VSV-PA, VSV-PB and VSV-PC are shown in Fig. 2 and listed in Table  5 . VSV-PA had two nucleotide changes and two resulting amino acid substitutions, VSV-PB had one mutation and one amino acid change, while VSV-PC had one mutation and one amino acid change. Amino acid 151 had common changes in VSV-PB and VSV-PC. This change was probably selected during the passages of persistently infected BHK-21 cells in nude mice, as neither tsG31 nor the first or second tumour passages of VSV-PC had this mutation (VSV-PC was isolated after seven tumour passages of persistently infected BHK-21 cells, and the mutation at position 151 in VSV-PC was found after the third tumour passage). The small number of mutations in the M protein for all three VSV-P type isolates is in contrast to the rather large numbers of M protein mutations found in an isolate from CAR-4 (persistently infected BHK-21 cells) after 10 years of in vitro persistence. The first 320 bases of the M protein of this 10 year isolate (called CAR-4-110 month) showed six mutations with six amino acid changes involving lysine or arginine substitutions. Thus, whereas in vitro persistent infections have the capacity to generate extensive M protein mutations, these were not seen at a high level in the nude mouseselected variants. s.B. VANDEPOL AND J. J. HOLLAND 
NS protein mutations in VSV-P mutants
VSV-PA had five mutations in NS with two amino acid substitutions as shown in Fig. 3 and listed in Table 6 . Two of these changes, at bases 22 and 75 (and the amino acid change resulting from that at base 75) are present in CAR-4-110 month, and therefore represent mutations occurring during the in vitro passaging of persistently infected cells prior to nude mouse selection. If these sites (bases 22 and 75) are omitted, VSV-PA showed three nucleotide changes resulting in one amino acid substitution during nude mouse passaging. VSV-PB showed no mutations in NS; VSV-PC showed three mutations resulting in one amino acid change (Fig. 3 
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6OO et al.,  1979; Santoli et al., 1978 ; Moiler et al., 1985 ; Welsh & Hallenbeck, 1980) , and NK cells have been implicated in the in vivo resistance of mice to some viruses (Bukowski et al., 1983, 1985; Habu et  al., 1984) . The original VSV-P mutant demonstrated that virus-encoded components were necessary to produce a suitable target for rejection of persistently infected cells by nude mice and NK cell lysis in vitro Minato et al., 1979) et al., 1985) . This study showed that expression of G protein alone via an expression vector in Cos cells did not render them susceptible to in vitro NK lysis. They further showed that cells infected with temperature-sensitive VSV mutants in either G or M were not lysed at the non-permissive temperature. These results suggest that NK cells recognize VSV G proteins structured by interaction with M (and possibly the nucleocapsid N protein). One might therefore predict that mutations in G, and M, and possibly N might alter the lysis of infected cells by NK cells. The presence of extensive G protein mutations in VSV-PA and clustered mutations in VSV-PB and VSV-PC suggests, but does not prove, that the G protein plays an important role in NK cell lysis of VSV-infected cells. The location of G protein mutations within the major antibody neutralization epitope in all three VSV-P isolates has several possible interpretations. While most nude mice have very low neutralizing antibody titres (usually < 1/10), such antibodies may select virus directly or indirectly via complement-mediated lysis of persistently infected cells or Fc receptor arming of nude mouse effector cells. Alternatively, NK cells may directly recognize these determinants. Should this be so, Fab fragments of anti-VSV antibodies might be useful in blocking NK cell-mediated lysis of virus-infected cells. The common M protein mutation in VSV-PB and VSV-PC (amino acid 151, base 492) suggests this site may contribute to the VSV-P phenotype in these isolates.
DISCUSSION
Many studies have shown that NK cells can lyse virus-infected target cells (Minato
. Recently, experiments utilizing a G protein expression vector and temperature-sensitive virus mutations in the VSV G and M proteins have been used to study NK cell lysis of VSV-infected cells (Moller
In contrast to the large numbers of G protein changes, VSV-PA showed only one amino acid substitution in the NS protein (after correction for mutations associated with in vitro persistence). This would suggest the NS protein probably does not have a role in NK cellmediated lysis of infected cells, and demonstrates that the large number of amino acid substitutions in G are not just a reflection of a high overall mutation rate in vivo. We plan to sequence the N gene of these three VSV-P type viruses to look for N protein mutations that might correlate with the VSV-P phenotype. We have recently shown that while BHK-21 cells persistently infected with VSV-P are NK-resistant in vitro and tumourigenic in nude mice. HeLa or mouse myeloma cells persistently infected with VSV-P are NK-sensitive in vitro and do not cause tumours in nude mice (S. B. VandePol & J. J. Holland, unpublished data). Thus, ascribing precise structural roles to particular mutations in VSV-P may prove very difficult since target cell components and/or NK cell subpopulations may be equally important. Proof of the role of the G or M protein mutations in VSV-PA, VSV-PB and VSV-PC must await cloning of their genes and the use of such clones in transfection vectors to complement temperature-sensitive mutant viruses in various cell types.
